People · Operator
Named in public records as an officer, director or promoter · active 2010–2025 · Other, Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Awarepoint Corp | — | Other | Series B | $79.2M | $8.3M | 2010 |
| selectIon, Inc. | — | Biotechnology | Series A | $19.6M | $16.1M | 2025 |
Stephen Zaniboni at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Stephen Zaniboni on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Brian Ascher | 1 | 11 |
| Vijay Lathi | 1 | 8 |
| Michael Foster | 1 | 8 |
| Cam Gallagher | 1 | 7 |
| Dana Mead | 1 | 7 |
| Tom Mawhinney | 1 | 6 |
| Brandon Hull | 1 | 5 |
| Thomas Mawhinney | 1 | 5 |
| Antonius Schuh | 1 | 5 |
| Edward Zander | 1 | 4 |
| Steve Zaniboni | 1 | 3 |
| Paul Wallace | 1 | 3 |
| Andrew Eckert | 1 | 3 |
| Mark Wiggins | 1 | 2 |
| Don Scifres | 1 | 2 |
| Jason Howe | 1 | 2 |
| Harold Koenig | 1 | 2 |
| Nicolas Nierenberg | 1 | 2 |
| Emily Wilson | 1 | 1 |
| John E. Deady | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.